Adenosine increases the cAMP content of the rat carotid body in vitro.
Monteiro
E C
EC
Department of Pharmacology, Faculty of Medical Sciences, New University of Lisbon, Portugal.
Vera-Cruz
P
P
Monteiro
T C
TC
Silva e Sousa
M A
MA
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015762:2-Chloroadenosine / Q000494:pharmacology; D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000818:Animals; D002344:Carotid Body / Q000187:drug effects* / Q000378:metabolism; D000242:Cyclic AMP / Q000096:biosynthesis*; D008297:Male; D009419:Nerve Tissue Proteins / Q000187:drug effects* / Q000502:physiology; D010477:Perfusion; D010627:Phenethylamines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D018047:Receptors, Purinergic P1 / Q000145:classification / Q000187:drug effects* / Q000502:physiology; D015290:Second Messenger Systems / Q000187:drug effects*
D009419:Nerve Tissue Proteins; D010627:Phenethylamines; D018047:Receptors, Purinergic P1; C061282:2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine; D015762:2-Chloroadenosine; C010192:9-(2-hydroxy-3-nonyl)adenine; D000242:Cyclic AMP; D000225:Adenine; D000241:Adenosine; D015056:1-Methyl-3-isobutylxanthine